PSYCHIATRIC-RELATED HEALTH CARE COSTS AND RISK OF HOSPITALIZATION AMONG MEDICAID PATIENTS WITH TYPE I BIPOLAR DISORDER WHO RELAPSE FREQUENTLY

Author(s)

Durden E1, Muser E2, Choi J3, Bagalman E4, Dirani R31Thomson Reuters, Austin, TX, USA, 2Ortho-McNeil Janssen Scientific Affairs, LLC, O'Fallon, MO, USA, 3Ortho-McNeil Janssen Scientific Affairs, LLC, Titusville, NJ, USA, 4Thomson Reuters, Washington, DC, USA

OBJECTIVES: To examine psychiatric-related health care costs and inpatient utilization among patients with type I bipolar disorder who relapse frequently within a large Medicaid database.  METHODS: A large multistate Medicaid claims database (MarketScan®) was used to identify patients aged 18 to 64 years with type I bipolar disorder; ≥1 prescription claim for lithium, an anticonvulsant, or an antipsychotic between January 1, 2004 and December 31, 2005; and ≥24 months’ continuous enrollment. Frequent relapse (FR) was defined as ≥2 clinically significant events (CSEs) occurring during a 12-month identification period beginning with the initial CSE (if any). CSEs included emergency room (ER) visits or inpatient hospitalizations (IH) with a principal diagnosis of bipolar disorder or a change in bipolar disorder medication(s). Patients were followed for a subsequent 12-month period to evaluate health care utilization and associated costs. Generalized linear modeling was used to estimate the impact of FR on psychiatric-related health care costs; logistic regression was used to estimate the impact of FR on psychiatric IH and ER visits. RESULTS:  Of 5527 patients with type I bipolar disorder, 53% relapsed frequently. Of the patients with FR, 75% were female. Close to one-third (29%) of patients who relapsed frequently in the identification period also relapsed frequently in the follow-up period. During the 12-month follow-up period, patients with FR had higher adjusted per-patient psychiatric-related health care costs (mean $6014 vs $3495; P<0.001), 3.7 times greater odds of psychiatric IH (P<0.01), and 3.1 times greater odds of psychiatric-related ER visits (P<0.01) than patients who did not relapse frequently. CONCLUSIONS: Medicaid patients with type I bipolar disorder who relapsed frequently had significantly higher adjusted psychiatric-related health care costs and greater odds of IH and ER events in a subsequent period than patients who did not relapse frequently. Supported by funding from Ortho-McNeil Janssen Scientific Affairs, LLC

Conference/Value in Health Info

2010-05, ISPOR 2010, Atlanta, GA, USA

Value in Health, Vol. 13, No. 3 (May 2010)

Code

PMH57

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies

Disease

Mental Health

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×